Haemonetics (HAE) Other Non-Current Liabilities (2010 - 2026)

Haemonetics' Other Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $59.4 million for Q1 2026.

• In Q1 2026, Other Non-Current Liabilities fell 12.91% year-over-year to $59.4 million; the TTM figure through Mar 2026 stood at $59.4 million (down 12.91% YoY), while the FY2026 annual figure was $59.4 million, down 12.91% from the prior year.
• Other Non-Current Liabilities was $59.4 million for Q1 2026 at Haemonetics, down from $63.6 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $92.3 million in Q2 2024 to a low of $59.4 million in Q1 2026.
• Historically, Other Non-Current Liabilities has averaged $75.7 million across 5 years, with a median of $74.9 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities gained 28.71% in 2024, then retreated 29.3% in 2025.
• A 5-year view of Other Non-Current Liabilities shows it stood at $78.2 million in 2022, then fell by 2.51% to $76.3 million in 2023, then rose by 17.97% to $90.0 million in 2024, then declined by 29.3% to $63.6 million in 2025, then slipped by 6.62% to $59.4 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $59.4 million (Q1 2026), $63.6 million (Q4 2025), and $66.1 million (Q3 2025), per Business Quant data.